Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

30.0%

6 terminated/withdrawn out of 20 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

1 recruiting6 withdrawn

Enrollment Performance

Analytics

N/A
4(28.6%)
Phase 1
4(28.6%)
Phase 2
4(28.6%)
Phase 4
2(14.3%)
14Total
N/A(4)
Phase 1(4)
Phase 2(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT07360808Not ApplicableRecruiting

Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis

Role: lead

NCT07117682Not ApplicableNot Yet Recruiting

Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian Reserve

Role: lead

NCT05797688Phase 1Withdrawn

Adipose-derived Stem Cells to Treat Chronic Wounds.

Role: collaborator

NCT03435172Not ApplicableSuspended

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

Role: lead

NCT02396238Not ApplicableCompleted

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Role: lead

NCT01556022Phase 2Completed

Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia

Role: lead

NCT02326961Phase 2Completed

Celution Prepared Adipose Derived Regenerative Cells in the Treatment of Osteoarthritis of the Knee

Role: lead

NCT02052427Phase 2Completed

Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)

Role: lead

NCT02770755Withdrawn

Registry of Celution Device for Processing ADRCs and Healing in Muscle and Ligament Sports Injuries

Role: lead

NCT02736110Withdrawn

Registry of Celution Device for the Processing of Adipose Derived Regenerative Cells (ADRCs) to Treat Osteoarthritis

Role: lead

NCT02735993Withdrawn

Cardiac REgistry of Celution Device for the Processing of Adipose-derived Regenerative Cells

Role: lead

NCT02732106Unknown

Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease

Role: lead

NCT02362386Completed

Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System

Role: lead

NCT02328625Withdrawn

Scleroderma Treatment With Celution Processed ADRCs Registry

Role: lead

NCT02045888Phase 1Withdrawn

Safety and Feasibility of ADRCs (Adipose Derived Regenerative Cells) in Patients With Grade II Hamstring Tears

Role: lead

NCT01216995Phase 2Completed

Safety and Efficacy of Adipose Derived Regenerative Cells (ADRCs) Delivered Via the Intracoronary Route in the Treatment of Patients With ST-elevation Acute Myocardial Infarction (AMI)

Role: lead

NCT00442806Phase 1Completed

Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction

Role: lead

NCT00426868Phase 1Completed

A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium

Role: lead

NCT00616135Phase 4Completed

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy

Role: lead

NCT00531739Phase 4Completed

SurgiWrapTM to Reduce Soft Tissue Attachment & Incidence Early Post-Operative Bowel Obstruction in Colorectal Surgery

Role: lead

All 20 trials loaded